Suppr超能文献

水溶性可冻干铝盐疫苗佐剂

Water-Soluble and Freezable Aluminum Salt Vaccine Adjuvant.

作者信息

Abucayon Erwin G, Belikow-Crovetto Ilya, Hussin Elizabeth, Kim Jiae, Matyas Gary R, Rao Mangala, Alving Carl R

机构信息

Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD 20817, USA.

U.S. Military HIV Research Program, Center for Infectious Diseases Research, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA.

出版信息

Vaccines (Basel). 2024 Jun 19;12(6):681. doi: 10.3390/vaccines12060681.

Abstract

Particulate aluminum salts have long occupied a central place worldwide as inexpensive immunostimulatory adjuvants that enable induction of protective immunity for vaccines. Despite their huge benefits and safety, the particulate structures of aluminum salts require transportation and storage at temperatures between 2 °C and 8 °C, and they all have exquisite sensitivity to damage caused by freezing. Here, we propose to solve the critical freezing vulnerability of particulate aluminum salt adjuvants by introducing soluble aluminum salts as adjuvants. The solubility properties of fresh and frozen aluminum chloride and aluminum triacetate, each buffered optimally with sodium acetate, were demonstrated with visual observations and with UV-vis scattering analyses. Two proteins, A244 gp120 and CRM, adjuvanted either with soluble aluminum chloride or soluble aluminum triacetate, each buffered by sodium acetate at pH 6.5-7.4, elicited murine immune responses that were equivalent to those obtained with Alhydrogel, a commercial particulate aluminum hydroxide adjuvant. The discovery of the adjuvanticity of soluble aluminum salts might require the creation of a new adjuvant mechanism for aluminum salts in general. However, soluble aluminum salts might provide a practical substitute for particulate aluminum salts as vaccine adjuvants, thereby avoiding the risk of inactivation of vaccines due to accidental freezing of aluminum salt particles.

摘要

颗粒状铝盐长期以来在全球范围内占据着核心地位,作为廉价的免疫刺激佐剂,能够诱导疫苗产生保护性免疫。尽管铝盐具有巨大的益处和安全性,但铝盐的颗粒结构需要在2℃至8℃之间运输和储存,并且它们对冷冻造成的损害都极为敏感。在此,我们提议通过引入可溶性铝盐作为佐剂来解决颗粒状铝盐佐剂关键的冷冻脆弱性问题。通过肉眼观察和紫外可见散射分析,展示了分别用醋酸钠进行最佳缓冲的新鲜和冷冻的氯化铝及三醋酸铝的溶解性。两种蛋白质,A244 gp120和CRM,分别用在pH 6.5 - 7.4下由醋酸钠缓冲的可溶性氯化铝或可溶性三醋酸铝作为佐剂,引发的小鼠免疫反应与使用商业颗粒状氢氧化铝佐剂Alhydrogel所获得的免疫反应相当。可溶性铝盐佐剂性的发现可能总体上需要为铝盐建立一种新的佐剂机制。然而,可溶性铝盐可能为颗粒状铝盐作为疫苗佐剂提供一种实用的替代物,从而避免因铝盐颗粒意外冷冻导致疫苗失活的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e68f/11209400/99045d9eb177/vaccines-12-00681-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验